During the February webinar (~48m), Jon Pilcher was asked about the possibility of combining the four disorders into one Phase 3 basket trial.
His answer was that it was unlikely – not only do the different disorders have slightly different endpoints, but also the FDA is going to want efficacy shown in each different disorder anyway.
During the February webinar (~48m), Jon Pilcher was asked about...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.09 |
Change
-0.220(1.14%) |
Mkt cap ! $2.437B | |||
| Open | High | Low | Value | Volume |
| $19.14 | $19.14 | $18.50 | $7.048M | 371.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 420 | $19.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.09 | 1 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.03 |
Change
-0.220 ( 0.79 %) |
||||
| Open | High | Low | Volume | ||
| $18.96 | $19.10 | $18.52 | 96070 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| NEU (ASX) Chart |